Sökning: hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Klinisk medicin) hsv:(Gastroenterologi)
> (2020-2023) >
Inventory study of ...
-
Ahmadpour, Doryaneh,1973Chalmers tekniska högskola,Chalmers University of Technology,Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden.;Motala Hosp, Inst Neurol, Dept Med Specialists, Motala, Sweden.,Region Östergötland, Medicinska specialistkliniken
(författare)
Inventory study of an early pandemic COVID- 19 cohort in South-Eastern Sweden, focusing on neurological manifestations
- Artikel/kapitelEngelska2023
Förlag, utgivningsår, omfång ...
-
2023-01-13
-
Public Library of Science (PLoS),2023
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:research.chalmers.se:338c77cd-026e-443d-8b85-9b3de3f96838
-
https://research.chalmers.se/publication/534262URI
-
https://doi.org/10.1371/journal.pone.0280376DOI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-499212URI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-192527URI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:152004680URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:art swepub-publicationtype
-
Ämneskategori:ref swepub-contenttype
Anmärkningar
-
Background Neurological manifestations in patients with COVID-19 have been reported previously as outcomes of the infection. The purpose of current study was to investigate the occurrence of neurological signs and symptoms in COVID-19 patients, in the county ofÖstergötland in southeastern Sweden. Methods This is a retrospective, observational cohort study. Data were collected between March 2020 and June 2020. Information was extracted from medical records by a trained research assistant and physician and all data were validated by a senior neurologist. Results Seventy-four percent of patients developed at least one neurological symptom during the acute phase of the infection. Headache (43%) was the most common neurological symptom, followed by anosmia and/or ageusia (33%), confusion (28%), hallucinations (17%), dizziness (16%), sleep disorders in terms of insomnia and OSAS (Obstructive Sleep Apnea) (9%), myopathy and neuropathy (8%) and numbness and tingling (5%). Patients treated in the ICU had a higher male presentation (73%). Several risk factors in terms of co-morbidities, were identified. Hypertension (54.5%), depression and anxiety (51%), sleep disorders in terms of insomnia and OSAS (30%), cardiovascular morbidity (28%), autoimmune diseases (25%), chronic lung diseases (24%) and diabetes mellitus type 2 (23%) founded as possible risk factors. Conclusion Neurological symptoms were found in the vast majority (74%) of the patients. Accordingly, attention to neurological, mental and sleep disturbances is warranted with involvement of neurological expertise, in order to avoid further complications and long-term neurological effect of COVID-19. Furthermore, risk factors for more severe COVID-19, in terms of possible co-morbidities that identified in this study should get appropriate attention to optimizing treatment strategies in COVID-19 patients.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Kristoffersson, AnnaMotala Hosp, Inst Neurol, Dept Med Specialists, Motala, Sweden.,Region Östergötland, Medicinska specialistkliniken(Swepub:liu)n/a
(författare)
-
Fredrikson, MatsLinköpings universitet,Avdelningen för inflammation och infektion,Forum Östergötland(Swepub:liu)matfr43
(författare)
-
Link, YuminLinköpings universitet,Avdelningen för neurobiologi,Medicinska fakulteten,Region Östergötland, Neurologiska kliniken i Linköping(Swepub:liu)yumli79
(författare)
-
Eriksson, AnneMotala Hosp, Inst Med, Dept Med Specialists, Motala, Sweden.,Region Östergötland, Medicinska specialistkliniken(Swepub:liu)n/a
(författare)
-
Iacobaeus, EllenKarolinska Institutet
(författare)
-
Landtblom, Anne-MarieLinköpings universitet,Uppsala universitet,Neurologi,Linkoping Univ Hosp, Dept Neurol, Linkoping, Sweden.;Uppsala Univ, Dept Med Sci, Uppsala, Sweden.,Avdelningen för neurobiologi,Medicinska fakulteten,Region Östergötland, Neurologiska kliniken i Linköping(Swepub:liu)annla55
(författare)
-
Haghighi, SaraUniversitetssjukhuset i Linköping,Linköping University Hospital,Motala Hosp, Inst Neurol, Dept Med Specialists, Motala, Sweden.;Linkoping Univ Hosp, Dept Neurol, Linkoping, Sweden.,Region Östergötland, Neurologiska kliniken i Linköping,Region Östergötland, Medicinska specialistkliniken(Swepub:liu)n/a
(författare)
-
Chalmers tekniska högskolaChalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden.;Motala Hosp, Inst Neurol, Dept Med Specialists, Motala, Sweden.
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:PLoS ONE: Public Library of Science (PLoS)18:1 January1932-62031932-6203
Internetlänk
Hitta via bibliotek
-
PLoS ONE
(Sök värdpublikationen i LIBRIS)
Till lärosätets databas